![]() |
|||||||||||
Home | Founder | What's New | In The News | Consulting | |||||||
![]() |
|||||||||||
H1N1 Consulting Paradigm Shift Intervention Monitoring |
Audio:May20
Jun17
Jul15
Aug19
![]() ![]() Live feed of underlying pandemic map data here Commentary
Adamantanes: Unknown Oseltamivir: Sensitive Zanamivir: Sensitive Peramivir: Unknown Other: Unknown The GISAID antiviral characterization sheet for A/Kansas/05/2010 has been corrected as indicated above. The initial sheet (posted yesterday) indicated (see list here) the isolate was resistant to Oseltamivir (Tamiflu) and Zanamivir (Relenza). This morning the CDC contacted Recombinomics to indicate the entry was in error and likely linked to the recent GISAID upgrade of the site (which now allows BLAST analysis of the database). The other NA sequence released with the Kansas sequence, A/Connecticut/23/2009, has not been tested for antiviral resisitance. Media Links Recombinomics
Presentations |
||||||||||
|
Webmaster:
webmaster@recombinomics.com
© 2010
Recombinomics. All
rights
reserved.